Capital Expenditures for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current capital expenditures (TTM) is $26.30M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingCapital ExpendituresSwitch metric
Latest period
$26.30M
YoY change
-50.7%
5Y CAGR
-9.7%
Peak year (2024)
$62.88M
Cumulative capital expenditures
$598.65M
CapEx history chart for Bio-Techne (TECH) from 1990 to 2025
CapEx history table for Bio-Techne (TECH) from 1990 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $31.01M | -50.7% | ||
| 2024 | $62.88M | +64.4% | ||
| 2023 | $38.24M | -14.8% | ||
| 2022 | $44.91M | +1.4% | ||
| 2021 | $44.30M | -14.4% | ||
| 2020 | $51.74M | +103.6% | ||
| 2019 | $25.41M | +21.4% | ||
| 2018 | $20.93M | +37.9% | ||
| 2017 | $15.18M | -10.2% | ||
| 2016 | $16.90M | -15.1% | ||
| 2015 | $19.91M | +44.0% | ||
| 2014 | $13.82M | -38.4% | ||
| 2013 | $22.45M | +273.2% | ||
| 2012 | $6.02M | +65.8% | ||
| 2011 | $3.63M | -21.8% | ||
| 2010 | $4.64M | -29.2% | ||
| 2009 | $6.56M | -59.9% | ||
| 2008 | $16.36M | +102.6% | ||
| 2007 | $8.08M | +75.5% | ||
| 2006 | $4.60M | -59.7% | ||
| 2005 | $11.41M | +207.5% | ||
| 2004 | $3.71M | -75.6% | ||
| 2003 | $15.19M | -31.8% | ||
| 2002 | $22.28M | +226.9% | ||
| 2001 | $6.81M | -77.6% | ||
| 2000 | $30.37M | -0.8% | ||
| 1999 | $30.60M | +920.0% | ||
| 1998 | $3.00M | -28.6% | ||
| 1997 | $4.20M | -34.4% | ||
| 1996 | $6.40M | +392.3% | ||
| 1995 | $1.30M | 0.0% | ||
| 1994 | $1.30M | -50.0% | ||
| 1993 | $2.60M | +333.3% | ||
| 1992 | $600,000 | -33.3% | ||
| 1991 | $900,000 | +125.0% | ||
| 1990 | $400,000 | — |
CapEx values are taken from Bio-Techne's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual capital expenditures for Bio-Techne (TECH) came in at $31.01M – plunged 50.7% year-over-year.
Across 2020–2025 (5 years), Bio-Techne capital expenditures produced a CAGR of -9.7% – with a net decline across the window.
Between 2024 and 2025, Bio-Techne capital expenditures plunged 50.7%, falling from $62.88M to $31.01M.
Across the available history, capital expenditures reached its high of $62.88M in 2024 and its low of $400,000 in 1990.
Within Healthcare, Bio-Techne (TECH) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.
Bio-Techne Capital Expenditures by Year
Bio-Techne Capital Expenditures 2025: $31.01M
Bio-Techne capital expenditures in 2025 was $31.01M, plunged 50.7% below 2024.
Bio-Techne Capital Expenditures 2024: $62.88M
Bio-Techne capital expenditures in 2024 was $62.88M, surged 64.4% from 2023. This figure represents the highest annual value in the available history.
Bio-Techne Capital Expenditures 2023: $38.24M
Bio-Techne capital expenditures in 2023 was $38.24M, declined 14.8% below 2022.
Bio-Techne Capital Expenditures 2022: $44.91M
Bio-Techne capital expenditures in 2022 was $44.91M, edged up 1.4% from 2021.
Bio-Techne Capital Expenditures 2021: $44.30M
Bio-Techne capital expenditures in 2021 was $44.30M.
See more financial history for Bio-Techne (TECH).
Sector peers — CapEx
Companies in the same sector as Bio-Techne, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Bio-Techne's capital expenditures?
- Latest reported capital expenditures for Bio-Techne (TECH) is $26.30M (period ending December 31, 2025).
How has Bio-Techne capital expenditures changed year-over-year?
- Bio-Techne (TECH) capital expenditures changed -50.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne capital expenditures?
- Bio-Techne (TECH) capital expenditures compound annual growth rate is -9.7% over the most recent 5 years available.
When did Bio-Techne capital expenditures hit its highest annual value?
- Bio-Techne capital expenditures reached its highest annual value of $62.88M in 2024.
What was Bio-Techne capital expenditures in 2024?
- Bio-Techne (TECH) capital expenditures in 2024 was $62.88M.
What was Bio-Techne capital expenditures in 2025?
- Bio-Techne (TECH) capital expenditures in 2025 was $31.01M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.